Media

Filter by Category

All Blog News Newsletters Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

Qualitative Development and Cognitive Evaluation of the Symptoms of Major Depressive Disorder (S-MDD), A Consortium-Developed Patient Reported Outcome Measure

C-Path receives COA qualification from FDA for the Symptoms of Major Depressive Disorder Scale (SMDDS)

Tucson, AZ – December 18, 2017 Critical Path Institute‘s (C-Path) Patient-Reported Outcome (PRO) Consortium annou

December 8, 2017

Characterizing Disease Progression for Parkinson’s Disease to implement efficient trial designs

December 8, 2017

Model-Informed Biomarker Qualification: Alzheimer and Parkinson Disease Imaging Biomarkers

C-Path and FARA announce collaborative data aggregation project for Friedreich’s ataxia

Tucson, AZ, and Downingtown, PA — December 4, 2017 — Critical Path Institute‘s (C-Path) Data Colla

January 12, 2017

A Standardised Method for Interpreting the Association Between Mutations and Phenotypic Drug Resistance in Mycobacterium Tuberculosis

January 12, 2017

Emerging Good Practices for Translatability Assessment (TA) of Patient-Reported Outcome (PRO) Measures

January 12, 2017

Patient-Reported Outcome (PRO) Consortium Translation Process: Consensus Development of Updated Best Practices

November 25, 2017

Chronic Pulmonary Insufficiency of Prematurity: Developing Optimal Endpoints for Drug Development

November 22, 2017

What Evidence Do We Need for Biomarker Qualification?

Previous7879 80...125 Next